glp-1 for nash Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives Endocrine - Glucagon-like Peptide-1 Receptor-based

Jorge Moreno, an obesity specialist and assistant professor of medicine at the Yale School of Medicine

The results of AWARD-CHN2 showed that the reduction of FPG by dulaglutide was similar to insulin glargine

Clinical trials of semaglutide show diarrhea occurs in approximately 2030% of patients, with the majority experiencing mild to moderate symptoms

Lovett says looking at the bigger picture can also help: Review your medication list with your doctor and pharmacist to make sure there is no drug interaction that is exacerbating the issue. Be sure to tell your healthcare provider about all the medications you take, including Rx and OTC medicines, vitamins, and supplements